Rebecca Byam
Chief Financial Officer · HCW Biologics Inc.
IndividualBuying only
- 2026
- May 27, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Rebecca Byam files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Scott T. Garrett - $270K in HCWB purchases and sales in the last 12 months
- Hing C. Wong - $220K in HCWB purchases and sales in the last 12 months
- Lee Flowers - $20K in HCWB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Rebecca Byam?
Rebecca Byam is a corporate insider, tracked as Chief Financial Officer of HCW Biologics Inc. (HCWB). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Rebecca Byam last file a Form 4?
The only primary Form 4 on record is dated 27 May 2026.
Has Rebecca Byam been buying or selling stock?
Recorded transactions: 2 open-market purchases ($20K) and 0 open-market sales across all tracked filings.
